- Home
- Applications
- cancer disease
Refine by
Cancer Disease Product Applications
32 applications found
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
ByAscelia Pharma AB based in Malmö, SWEDEN
Premium
Novel cell therapies show great promise as treatments for a variety of complex diseases including cancers and neurodegenerative disorders. Flow imaging microscopy supports drug product analysis in order to advance the development of these therapies. ...
ByYokogawa Fluid Imaging Technologies, Inc. based in Scarborough, MAINE (USA)
Medical isotopes are used in the medical industry to diagnose and treat cancer, heart disease, and other medical conditions. There are more than 40 million medical procedures worldwide that use medical isotopes, and every 1 in 50 people undergo a nuclear diagnostic procedure annually in developing countries. ...
ByARC Clean Technology, Inc. based in Saint John, NEW BRUNSWICK (CANADA)
Next Generation Sequencing (NGS) data obtained from cfDNA, can be used to monitor prenatal health, organ transplant reception or rejection, cancer and other ...
ByClaret Bioscience based in Santa Cruz, CALIFORNIA (USA)
It holds great promise for the treatment of autoimmune diseases, cancer, and the prevention of transplant ...
ByNanovex Biotechnologies based in Llanera, SPAIN
They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune response in order to fully engage and fight tumor ...
ByKiadis Pharma NV based in Amsterdam, NETHERLANDS
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Cancer is a group of diseases in which normal cells change and grow out of control. In breast cancer, the cancerous cells are usually cells of the lobules and ducts (ie, the glands that produce milk and the channels that carry milk to the nipple). Keep in mind that cancer, or carcinoma, of the breast can be broadly divided into two categories : ...
ByAurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA)
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
ByBiocept based in San Diego, CALIFORNIA (USA)
One of the that cancer can be a serious disease is its ability to spread to other parts of the body beyond the location of the primary tumour. When cancer cells spread to distant lymph nodes, tissues or organs, it is called metastatic ...
ByAscelia Pharma AB based in Malmö, SWEDEN
Copy number variation (CNV) is a type of structural variation and it encompasses duplication or deletion events that affect a considerable section of the genome. Those events may be mirrored by changes in gene expression levels and are consequently involved in pathogenesis. Partek tools enable you to start with raw data, detect amplified or deleted regions, and interpret or integrate the data with other assays such as gene expression. ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
The concept behind protein arrays is the immobilisation of sets of proteins, up to very large numbers, on solid supports, to perform miniaturised, multiplexed binding assays with a variety of potential ligands or interactants (see powerpoint presentation on right). HuProt v4 human proteome arrays as used at CPA comprise full length human proteins, many of which will retain their native conformation. HuProt arrays can be distinguished from arrays of peptides, used primarily to identify linear epitopes, or protein ...
ByCambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM
The Promise: With modern diagnostic and imaging technologies, cancer can be detected earlier than ever before. And with earlier detection comes the promise of a surgical cure—that is, the complete removal (or resection) of all tumor tissue from a patient. Research has shown that patients with surgical cures have fewer complications in recovery and a greatly enhanced survival rate when compared to patients who do not achieve surgical ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
Thermal Management: Pyroid HT pyrolytic graphite thermal spreaders and thermal vias are a powerful new material solution in the battle against thermal heat in state-of-the-art electronic circuits and devices. HT material matches the heat spreading capability of CVD diamond at 1700 W/mK but at substantially better economics. ...
ByCETCO based in New York, NEW YORK (USA)
At Recover U we take a natural approach to well-being. PEMF (pulsed electromagnetic field) therapy is used to reactivate the body’s innate ability to heal itself. This healing modality has been used extensively in Europe for more than 70 years. Currently, in North America, PEMF is enjoying a true renaissance in the world of alternative and complementary medicine. There have been many talks on the method. Dr. Oz has extensively explained its benefits on his talk show. NASA has developed a device that uses ...
ByRecover U Technologies and Services Inc. based in Toronto, ONTARIO (CANADA)
Protein-based drugs are the fastest growing class of drugs for the treatment of many diseases in humans, ranging from cancer to Alzheimer’s disease. Accurate viscosity values of proteins are essential in understanding behavior, designing delivery systems, and accurately determining particle size/hydrodynamic ...
ByRheoSense Inc based in San Ramo, CALIFORNIA (USA)
Maximize the probability of your clinical trial success by accelerating patient enrollment and flexible operations. Whether it is investigator-initiated study, observational study, phase 0, 1, 2, 3, or 4 post-market trials, real-world evidence generation to supplement your randomized controlled clinical trial, maximizing the speed of patient enrollment is the proven way to minimize your ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)
Unlike conventional vaccination strategies, cancer vaccines are designed to mount responses against tumor-specific antigens, arising from somatic mutations specific to the cancer genome. They promise a highly tailored approach by targeting patient-specific ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Save 70% of your time and maximize the probability of success of your clinical study. Avoid common pitfalls by starting your cohort study, patient registry, observational data collection, or clinical trial on Jeeva eClinical cloud platform. Save over 70% of the effort involved in toggling between numerous tools, coordination between multiple channels of engagement between study team and participants, participants use their own mobile device, and study specific data governance. ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)
CROs can differentiate their services to sponsors with the white-labeled Jeeva eClinical technology platform advantage. Maximize the probability of winning contracts with sponsors by differentiating your proposals with Jeeva eClinical cloud. Sponsors want to know how you can ensure faster patient recruitment and better retention compared to your peers. Jeeva can rapidly turnaround with a budget proposal and branded material for inclusion in your response to sponsor RFPs and support you throughout the ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)